Description
Exploring the Potential of GHRP-2: A Growth Hormone Releasing Polypeptide
GHRP-2 emerges as a growth hormone releasing polypeptide renowned for its short half-life and potent effects. Comprising six amino acids, GHRP-2, also known as KP-102, exerts its influence primarily through G-protein coupled receptors. Studies, as documented in the Journal of Endocrinology and Metabolism, indicate that GHRP-2 administration to growth hormone deficient individuals leads to elevated plasma growth hormone levels.
This synthetic hexapeptide serves as a catalyst for hypothalamic activities, stimulating the pituitary gland to unleash growth hormones. While GHRP-2 exhibits the ability to increase IGF-1 levels, its effects extend beyond mere hormonal modulation. Notably, the compound partially triggers the secretion of prolactin, ACTH, and cortisol levels.
Facilitating growth hormone release involves augmenting calcium ion influx into cells, a mechanism facilitated by the synthetic molecule. Intriguingly, ongoing research endeavors are probing into the potential anti-inflammatory effects of GHRP-2, further broadening its therapeutic scope.
With a molecular weight of 817.97 and a molecular formula of C45H55N9O6, GHRP-2 emerges as a promising candidate for growth hormone modulation and beyond.
GHRP-2 Chemical Profile:
- CAS: 158861-67-7
- Formula: C45H55N9O6
- Molecular Weight: 817.9
- Peptide Purity: > 99.0%
- Chain: D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2